Your browser doesn't support javascript.
loading
Long-term disease interactions amongst surgical patients: a population cohort study.
Fowler, Alexander J; Wahedally, M A Hussein; Abbott, Tom E F; Prowle, John R; Cromwell, David A; Pearse, Rupert M.
Afiliación
  • Fowler AJ; School of Medicine and Dentistry, Queen Mary University of London, London, UK; Royal College of Surgeons of England, London, UK. Electronic address: a.fowler@qmul.ac.uk.
  • Wahedally MAH; Royal College of Surgeons of England, London, UK.
  • Abbott TEF; School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Prowle JR; School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Cromwell DA; Royal College of Surgeons of England, London, UK; London School of Hygiene and Tropical Medicine, London, UK.
  • Pearse RM; School of Medicine and Dentistry, Queen Mary University of London, London, UK.
Br J Anaesth ; 131(2): 407-417, 2023 08.
Article en En | MEDLINE | ID: mdl-37400340
ABSTRACT

BACKGROUND:

The average age of the surgical population continues to increase, as does prevalence of long-term diseases. However, outcomes amongst multi-morbid surgical patients are not well described.

METHODS:

We included adults undergoing non-obstetric surgical procedures in the English National Health Service between January 2010 and December 2015. Patients could be included multiple times in sequential 90-day procedure spells. Multi-morbidity was defined as presence of two or more long-term diseases identified using a modified Charlson comorbidity index. The primary outcome was 90-day postoperative death. Secondary outcomes included emergency hospital readmission within 90 days. We calculated age- and sex-adjusted odds ratios (OR) with 95% confidence intervals (CI) using logistic regression. We compared the outcomes associated with different disease combinations.

RESULTS:

We identified 20 193 659 procedure spells among 13 062 715 individuals aged 57 (standard deviation 19) yr. Multi-morbidity was present among 2 577 049 (12.8%) spells with 195 965 deaths (7.6%), compared with 17 616 610 (88.2%) spells without multi-morbidity with 163 529 deaths (0.9%). Multi-morbidity was present in 1 902 859/16 946 808 (11.2%) elective spells, with 57 663 deaths (2.7%, OR 4.9 [95% CI 4.9-4.9]), and 674 190/3 246 851 (20.7%) non-elective spells, with 138 302 deaths (20.5%, OR 3.0 [95% CI 3.0-3.1]). Emergency readmission followed 547 399 (22.0%) spells with multi-morbidity compared with 1 255 526 (7.2%) without. Multi-morbid patients accounted for 57 663/114 783 (50.2%) deaths after elective spells, and 138 302/244 711 (56.5%) after non-elective spells. The rate of death varied five-fold from lowest to highest risk disease pairs.

CONCLUSION:

One in eight patients undergoing surgery have multi-morbidity, accounting for more than half of all postoperative deaths. Disease interactions amongst multi-morbid patients is an important determinant of patient outcome.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Complicaciones Posoperatorias / Medicina Estatal Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Humans Idioma: En Revista: Br J Anaesth Año: 2023 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Complicaciones Posoperatorias / Medicina Estatal Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Humans Idioma: En Revista: Br J Anaesth Año: 2023 Tipo del documento: Article